Association of progression or regression of coronary artery atherosclerosis with long-term prognosis.
The association between coronary atherosclerosis progression or regression and long-term prognosis remains poorly defined. We assessed the association of atherosclerosis progression or regression with long-term mortality and factors that promote angiographic progression or regression of coronary atherosclerosis in patients with angiographically proven coronary artery disease.



The study included 605 patients with coronary artery disease who underwent coronary angiography at baseline and at 2 years later. Pan-coronary artery tree quantitative coronary angiography was performed. Of 6259 coronary segments (10.3 lesions per patient) analyzed, 1790 non-stented segments with ≥25% diameter stenosis at baseline were included. Atherosclerosis progression or regression was defined as a decrease or increase in the mean minimal lumen diameter (MLD) of the non-stented segments of ≥0.2 mm in the 2-year angiography compared to baseline angiography. The primary outcome was all-cause mortality.



Based on the change in mean MLD between baseline and 2-year angiography, patients were divided into 3 groups: the group with progression of atherosclerosis (n=53; 8.8%), the group with no progression or regression of atherosclerosis (n=472; 78.0%) and the group with regression of atherosclerosis (n=80; 13.2%). There were 126 deaths over 8-year follow-up: 17 deaths among patients with progression, 103 deaths among patients with no progression/regression and 6 deaths among patients with regression (Kaplan-Meier estimates of mortality, 37.5%, 25.2% and 8.9%, respectively; adjusted hazard ratio=1.16, 95% confidence interval 1.05 to 1.29, P=.004 for 0.1 mm reduction in mean MLD).



Progression or regression of coronary atherosclerosis in non-treated coronary segments was significantly associated with 8-year mortality.
Deutsches Herzzentrum München, Technische Universität, Munich, Germany. Electronic address: ndrepepa@dhm.mhn.de.
Gjin
G
Ndrepepa
Division of Cardiovascular Medicine, Ohashi Hospital, Toho University Medical Center, Tokyo, Japan.
Raisuke
R
Iijima
Deutsches Herzzentrum München, Technische Universität, Munich, Germany.
Sebastian
S
Kufner
Deutsches Herzzentrum München, Technische Universität, Munich, Germany.
Siegmund
S
Braun
Deutsches Herzzentrum München, Technische Universität, Munich, Germany.
Salvatore
S
Cassese
Deutsches Herzzentrum München, Technische Universität, Munich, Germany.
Robert A
RA
Byrne
Deutsches Herzzentrum München, Technische Universität, Munich, Germany.
Jonas
J
Sorges
Deutsches Herzzentrum München, Technische Universität, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
Stefanie
S
Schulz-Schüpke
1.Medizinische Klinik, Klinikum rechts der Isar, Technische Universität, Munich, Germany.
Petra
P
Hoppmann
Deutsches Herzzentrum München, Technische Universität, Munich, Germany.
Massimiliano
M
Fussaro
1.Medizinische Klinik, Klinikum rechts der Isar, Technische Universität, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
Karl-Ludwig
KL
Laugwitz
Deutsches Herzzentrum München, Technische Universität, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
Heribert
H
Schunkert
Deutsches Herzzentrum München, Technische Universität, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
Adnan
A
Kastrati
D000368:Aged; D015992:Body Mass Index; D015897:Comorbidity; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging* / Q000453:epidemiology / Q000601:surgery; D023921:Coronary Stenosis / Q000000981:diagnostic imaging* / Q000453:epidemiology / Q000601:surgery; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000453:epidemiology; D018450:Disease Progression; D054855:Drug-Eluting Stents; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D050177:Overweight / Q000453:epidemiology; D062645:Percutaneous Coronary Intervention; D011379:Prognosis; D016016:Proportional Hazards Models; D020127:Recovery of Function; D012307:Risk Factors
D007004:Hypoglycemic Agents; D007328:Insulin